Literature DB >> 12525875

A family of episodic ataxia type 2: no evidence of genetic linkage to the CACNA1A gene.

Hiroyuki Hirose1, Takashi Arayama, Junko Takita, Takashi Igarashi, Yasuhide Hayashi, Yoshiro Nagao.   

Abstract

Episodic ataxia type 2 (EA2) has been reported to result from mutations in the CACNA1A gene, located on chromosome 19p13. We describe a family with episodic ataxia, clinically indistinguishable from EA2, that was not caused by CACNA1A gene mutation. The proband is an 11-year-old boy, who has had 6 cerebellar ataxic attacks since 8 years of age. His attacks occurred almost monthly, lasting for 2 to 3 days. He was treated successfully with acetazolamide. His identical twin, mother and grandmother developed ataxic attacks at age 10, 34, and 50, respectively. The symptoms in his grandmother improved gradually without medication. His mother and identical twin took acetazolamide with a good response. We examined the CACNA1A gene for this family but did not detect any mutations. Furthermore, there was no evidence of genetic linkage between the CACNA1A gene and the symptomatic patients in this family. This suggests that the cause of EA2 can be heterogeneous, that is, defects of genes other than CACNA1A might be the cause of EA2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525875

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  4 in total

Review 1.  Migraine genetics: an update.

Authors:  J Haan; E E Kors; Kaate R J Vanmolkot; Arn M J M van den Maagdenberg; Rune R Frants; M D Ferrari
Journal:  Curr Pain Headache Rep       Date:  2005-06

2.  Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial.

Authors:  Carolin Muth; Julian Teufel; Ludger Schöls; Matthis Synofzik; Christiana Franke; Dagmar Timmann; Ulrich Mansmann; Michael Strupp
Journal:  Neurol Clin Pract       Date:  2021-08

3.  Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

Authors:  Sergey V Ivanov; Jerrold M Ward; Lino Tessarollo; Dorothea McAreavey; Vandana Sachdev; Lameh Fananapazir; Melissa K Banks; Nicole Morris; Draginja Djurickovic; Deborah E Devor-Henneman; Ming-Hui Wei; Gregory W Alvord; Boning Gao; James A Richardson; John D Minna; Michael A Rogawski; Michael I Lerman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 4.  Episodic ataxia type 2.

Authors:  Michael Strupp; Andreas Zwergal; Thomas Brandt
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.